×

DoDo is now offically a Dodo

Tweet ProfG suggested a two trials because he though the effect of ocrelizumab on progression could be due to antibody getting into the CNS and suggested a DOuble DOse the Dodo trial. The other trial was a watch an wait so treat for a while…

Late Breaking News O hand give hope for Chariot MS

Tweet ProfG is presenting news of the O-hand ocrelizumab primary progression and importantly it showed a positive result in people who were at the EDSS 8 end and shows that hand function can be be saved. It says that people in wheelchairs can respond to…

The changing Face of MS

Tweet ECTRIMS 2025 is in coming to an end and whilst we wait for the late-breaking session rather than look at the science, I note the demise of MS pharma. As the gravy train for some ends it is evident that generic and biosimilar prodicing…

I’m Still Standing, but Barely

By multipe sclerosis and DWTS This is how my confused, layered, weird, MS brain works. “I wonder what I’ll do tonight. Is there a good true crime documentary to watch? Oh wait, Dancing with the Stars new season starts at 8PM- yay! I miss head…

HSCT is more effective than anti-CD20 in the real World

Tweet Abit of a NSS momentpeople with this HSCT had few relapses but more inections that anti-CD20. Abstract Number: 1586/P848 Effectiveness of autologous haematopoietic stem cell transplant in comparison with anti-CD20 therapies in relapsing-remitting multiple sclerosis Tomas Kalincik et al. Introduction: Autologous hematopoietic stem cell…

ECTRIMS 2025: Cognitive changes may precede physical decline

People with multiple sclerosis (MS) seem to experience significant changes in cognition more than a year before significant physical decline is evident, a study found. While measures of processing speed, […] The post ECTRIMS 2025: Cognitive changes may precede physical decline appeared first on Multiple…